A recently listed Clinical Trial aims to recruit rosacea sufferers to find out how well they are getting on with their usage of Finacea, Metrogel and Mirvaso. The trial outcomes are several, but include the recording of adverse reactions to treatments, patient satisfaction and likelihood of switching rosacea treatment.
The trial is being sponsored by Bayer, the makers of Finacea. Given the trial outcomes it is easy to see the trial as an attempt by Bayer to get an understanding of how well rosacea sufferers fare with Finacea compared to Metrogel and Mirvaso. This understanding will include adverse events and how likely current satisfaction with a treatment might lead sufferers to consider switching treatments.
Clinical Trial NCT02602470
A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea
Purpose:To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.
- Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251)
- Azelaic Acid Cream
- Metronidazole gel
- Metronidazole cream
- Metronidazole Emulsion
- Metronidazole Lotion
- Brimonidine Tartrate Gel
Self-reported concerns and importance of such concerns regarding their current topical rosacea treatments
Self-reported adverse events associated with patients’ satisfaction/dissatisfaction
Self-reported likelihood of switching to a topical rosacea treatments
Have you been able to try both Finacea and Mirvaso or Metrogel ?
How bad would a treatment have to be before you would try something else?